PTC THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.9 USD | -2.04% |
|
-0.08% | +33.89% |
| May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
| May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-06-10 | 2024-06-11 | 2024-06-12 | 2024-06-13 | |
|---|---|---|---|---|
| Last | 37.61 $ | 37.69 $ | 37.67 $ | 36.9 $ |
| Volume | 1 257 965 | 588 025 | 645 832 | 774 672 |
| Change | +2.98% | +0.21% | -0.05% | -2.04% |
| Opening | 36.12 | 37.18 | 38.96 | 37.60 |
| High | 38.27 | 37.80 | 39.95 | 38.12 |
| Low | 36.12 | 36.60 | 36.98 | 36.70 |
Performance
| 1 day | -2.04% | ||
| 1 week | -0.08% | ||
| Current month | +1.49% | ||
| 1 month | +16.40% | ||
| 3 months | +19.84% | ||
| 6 months | +32.21% | ||
| Current year | +33.89% | ||
| 1 year | -16.27% | ||
| 3 years | -14.09% | ||
| 5 years | -11.51% | ||
| 10 years | +46.25% |
Volumes
marketsDaily volume
774 672
Estimated daily volume
774 672
Avg. Volume 20 sessions
778 294
Daily volume ratio
1.00
Avg. Volume 20 sessions USD
28 719 048.60
Record volume 1
28 675 120
Record volume 2
26 581 960
Record volume 3
21 662 070
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
2 889 167 890
Net sales (USD)
937 822 000
Number of employees
1 022
Sales / Employee (USD)
917 634
Free-Float
97.58 %
Free-Float capitalization (USD)
2 819 279 944
Average Daily Capital Traded
0.99%
Highs and lows
1 week
36.12
39.95
1 month
31.9240.69
Current year
23.5840.69
1 year
17.5344.66
3 years
17.5359.84
5 years
17.5370.82
10 years
4.0378.72
Indicators
Moving average 5 days
37.28
Moving average 20 days
36.81
Moving average 50 days
31.98
Moving average 100 days
30.09
Price spread / (MMA5)
+1.02%
Price spread / (MMA20)
-0.25%
Price spread / (MMA50)
-13.32%
Price spread / (MMA100)
-18.47%
STIM
RSI 9 days
59.81
RSI 14 days
60.36
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -2.04% | -0.08% | +33.89% | -16.27% | 2.89B | ||
| +0.68% | -1.34% | +17.73% | +40.03% | 123B | ||
| -0.11% | +2.57% | +16.88% | +33.78% | 111B | ||
| -1.95% | -5.71% | -9.04% | -16.96% | 23.63B | ||
| +2.37% | +1.64% | +4.40% | -1.97% | 22.58B | ||
| -0.84% | +5.68% | -38.15% | -34.60% | 17.61B | ||
| -1.03% | +5.57% | -7.75% | -21.59% | 17.6B | ||
| -1.25% | -6.00% | -15.36% | -31.61% | 17.26B | ||
| +1.22% | +2.40% | +3.42% | +42.41% | 13.55B | ||
| +4.18% | +6.44% | +29.63% | -3.74% | 11.34B | ||
| -0.03% | +7.80% | +98.87% | +217.35% | 9.94B | ||
| -4.55% | -6.21% | -27.42% | -37.70% | 8.34B | ||
| +0.11% | +2.07% | +17.85% | +39.43% | 8.04B | ||
| -2.61% | -7.70% | +1.50% | +37.57% | 7.53B | ||
| +1.32% | +3.30% | -1.91% | +21.43% | 7.48B | ||
| -3.75% | +4.22% | -59.93% | -73.14% | 6.67B | ||
| Average | -0.50% | +1.14% | +4.04% | +12.15% | ||
| Weighted average by Cap. | +0.03% | +0.73% | +9.40% | +22.75% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
cc24516f8a5ee6e9d86803.1SRER5fERTxQE9ePjq5xAlKDXxIRbObUiLj256SDFRI.gkUnP_-8AEwRaZrco8khRTPPClUnBY-u3eidjejcTVu_bDQU2Z0DESoq4w
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 36.9 | 113,736 | 525,013 |
| 03:59:59 pm | 36.89 | 133 | 411,277 |
| 03:59:56 pm | 36.89 | 115 | 411,144 |
| 03:59:56 pm | 36.89 | 100 | 411,029 |
| 03:59:56 pm | 36.89 | 100 | 410,929 |
| 03:59:56 pm | 36.9 | 100 | 410,829 |
| 03:59:56 pm | 36.9 | 100 | 410,729 |
| 03:59:56 pm | 36.9 | 100 | 410,629 |
| 03:59:56 pm | 36.9 | 100 | 410,529 |
| 03:59:56 pm | 36.9 | 100 | 410,429 |
Monthly variations
Annual change
| 2024 | +33.89% | ||
| 2023 | -27.80% | ||
| 2022 | -4.17% | ||
| 2021 | -34.74% | ||
| 2020 | +27.07% | ||
| 2019 | +39.95% | ||
| 2018 | +105.76% | ||
| 2017 | +52.89% | ||
| 2016 | -66.33% | ||
| 2015 | -37.42% | ||
| 2014 | +205.07% | ||
| 2013 | +2.91% |
- Stock Market
- Equities
- PTCT Stock
- Quotes PTC Therapeutics, Inc.
